about
Multiple system atrophy: cellular and molecular pathology.Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathiesGlia and alpha-synuclein in neurodegeneration: A complex interactionAntidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophyalpha-Synuclein affects the MAPK pathway and accelerates cell death.Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicityOculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients.Axon-myelin interactions during a viral infection of the central nervous system17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagyEarly limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.Neuropathology of synuclein aggregates.Visuoperception test predicts pathologic diagnosis of Alzheimer disease in corticobasal syndromeOrganization and functional roles of the cytoskeleton in oligodendrocytes.Protein aggregates and dementia: is there a common toxicity?Iron and Parkinson's disease.Glial cell inclusions and the pathogenesis of neurodegenerative diseasesGenetic neuropathology of Parkinson's disease.Iron in neurodegenerative disorders.Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophySelective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse modelLaryngeal dystonia in the course of multiple system atrophy: a cause of postoperative respiratory insufficiency.Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.A Rapid, Semi-Quantitative Assay to Screen for Modulators of Alpha-Synuclein Oligomerization Ex vivo.DOPAL is transmissible to and oligomerizes alpha-synuclein in human glial cells.Review: Novel treatment strategies targeting alpha-synuclein in multiple system atrophy as a model of synucleinopathyExpanding the spectrum of neuronal pathology in multiple system atrophy.The cytoskeleton in oligodendrocytes. Microtubule dynamics in health and disease.Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.Neuropathology and Cellular Pathogenesis of Spinocerebellar Ataxia Type 12Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophyAnti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy.Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts.Milestones in PD genetics.Mechanisms of action of brain insulin against neurodegenerative diseases.Immunotherapy targeting α-synuclein, with relevance for future treatment of Parkinson's disease and other Lewy body disorders.Visual signs and symptoms of multiple system atrophy.Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.Profile of cognitive impairment and underlying pathology in multiple system atrophy.Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy.
P2860
Q24535446-76E84B2C-4541-4B08-924A-4A593D5FE1ACQ24554351-923FE69C-488B-4C93-9C15-ECB740E37886Q26851153-591B97F7-0962-4A69-AC4D-3CA0C179B9B8Q28395248-85AF6D2B-8DAE-48AB-BE64-CC5780CA8679Q31010246-23293A8F-78E7-4B86-BC27-3BB97D2A8FBBQ33280345-B0D9FF70-8F80-4035-B1B0-374F29910C4FQ33326684-8A44A58E-46CC-4A57-AA0C-3ACD44C5B030Q33506620-56ADC5D5-8D86-4D74-82AE-6202BE4251D4Q33525555-61052F47-664E-4EDA-AE2A-D8DF45F40837Q33543381-28B0B30E-B3A1-44C3-9607-49A8E0B837DCQ33957376-D3AC3384-A127-4101-A0A3-A5DDA785B336Q34079332-B06183BC-1777-484E-A501-1E4D9BA38E75Q34199602-DFDF192C-5F72-42B2-BF60-AD1E31F8FB0FQ34498308-1E3C7725-CE53-46EF-B7F0-35392539B09CQ34529356-B0B5F399-4A61-4536-8D64-C721A805BEDDQ34538330-3DD1ED65-A7FF-4E01-8CFE-0AE4D4638A95Q34825312-9C0AF252-270F-40A7-8DEB-B94F7AFBB51CQ35112542-219EFF66-B8C5-442D-9B14-C19E08141E3BQ35544737-09E5406F-D6B7-4E65-86C5-48C37C8794CDQ35747138-5C57EFE5-90C6-48EE-9604-B445130974DAQ35973697-51C1A013-2FFF-47F0-B801-EC5E85D5CDB1Q35986671-5D05BB7F-474B-43DE-9220-67ACA6684480Q36475337-F6D4F3E7-EB53-44DD-B517-A020512466ADQ36494097-292A0937-6545-4E5A-AA0F-F75A62E932FFQ36672116-9CD9553A-B303-4687-9F2E-54AA36C7E091Q36825501-E263E325-9906-44F8-8F49-CA569BA38288Q37023835-2BB5D6FD-193C-4134-B6D2-B61B326FF27BQ37092530-C549E938-F8D6-41A7-8CFD-CE54D7A6D39EQ37100913-2B9FAF5D-1415-4F8E-927A-0C55D6A771FDQ37451446-D6D0C77A-0D13-4D83-852A-C63FE5B6B172Q37565960-720A448D-F109-4903-92F3-7AE70246BAE2Q37586721-2D013BC3-6E94-43CB-AEFB-CD4DA1B1C8FEQ37874476-6AE79678-1AD2-46D6-869E-C16E953FF06FQ37882589-38C43F01-7FEE-44AC-B9BB-BA1F48ABB439Q38176522-70403429-557B-4098-969D-B039DACA354AQ38184645-F316865A-74E0-45A1-9DBD-AA611F55A149Q38254318-20754C18-C37B-4320-9724-FF1285DA9B43Q38585651-085504FD-A33D-4689-93F5-4BE09141E25BQ39177273-86A4A714-5256-412B-B16D-0E9BCFE48E25Q42493792-665B8AAE-E875-4FD8-BAB2-1D2D53EB4BF3
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Multiple system atrophy: a sporadic synucleinopathy.
@ast
Multiple system atrophy: a sporadic synucleinopathy.
@en
type
label
Multiple system atrophy: a sporadic synucleinopathy.
@ast
Multiple system atrophy: a sporadic synucleinopathy.
@en
prefLabel
Multiple system atrophy: a sporadic synucleinopathy.
@ast
Multiple system atrophy: a sporadic synucleinopathy.
@en
P2093
P2860
P1433
P1476
Multiple system atrophy: a sporadic synucleinopathy.
@en
P2093
P2860
P304
P356
10.1111/J.1750-3639.1999.TB00553.X
P577
1999-10-01T00:00:00Z